These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11132390)

  • 21. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de Bruyn G; Garner P
    Cochrane Database Syst Rev; 2003; (1):CD001166. PubMed ID: 12535403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.
    Batbold U; Butov DO; Kutsyna GA; Damdinpurev N; Grinishina EA; Mijiddorj O; Kovolev ME; Baasanjav K; Butova TS; Sandagdorj M; Batbold O; Tseveendorj A; Chunt E; Zaitzeva SI; Stepanenko HL; Makeeva NI; Mospan IV; Pylypchuk VS; Rowe JL; Nyasulu P; Jirathitikal V; Bain AI; Tarakanovskaya MG; Bourinbaiar AS
    Immunotherapy; 2017 Jan; 9(1):13-24. PubMed ID: 27868466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
    Luo Y;
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):43-7. PubMed ID: 11802939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).
    Efremenko YV; Butov DA; Prihoda ND; Zaitzeva SI; Yurchenko LV; Sokolenko NI; Butova TS; Stepanenko AL; Kutsyna GA; Jirathitikal V; Bourinbaiar AS
    Hum Vaccin Immunother; 2013 Sep; 9(9):1852-6. PubMed ID: 23782489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homeopathic treatment in addition to standard care in multi drug resistant pulmonary tuberculosis: a randomized, double blind, placebo controlled clinical trial.
    Chand KS; Manchanda RK; Mittal R; Batra S; Banavaliker JN; De I
    Homeopathy; 2014 Apr; 103(2):97-107. PubMed ID: 24685414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial.
    Penn-Nicholson A; Tameris M; Smit E; Day TA; Musvosvi M; Jayashankar L; Vergara J; Mabwe S; Bilek N; Geldenhuys H; Luabeya AK; Ellis R; Ginsberg AM; Hanekom WA; Reed SG; Coler RN; Scriba TJ; Hatherill M;
    Lancet Respir Med; 2018 Apr; 6(4):287-298. PubMed ID: 29595510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed
    Bourinbaiar AS; Batbold U; Efremenko Y; Sanjagdorj M; Butov D; Damdinpurev N; Grinishina E; Mijiddorj O; Kovolev M; Baasanjav K; Butova T; Prihoda N; Batbold O; Yurchenko L; Tseveendorj A; Arzhanova O; Chunt E; Stepanenko H; Sokolenko N; Makeeva N; Tarakanovskaya M; Borisova V; Reid A; Kalashnikov V; Nyasulu P; Prabowo SA; Jirathitikal V; Bain AI; Stanford C; Stanford J
    J Clin Tuberc Other Mycobact Dis; 2020 Feb; 18():100141. PubMed ID: 31890902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7).
    Butov DA; Efremenko YV; Prihoda ND; Zaitzeva SI; Yurchenko LV; Sokolenko NI; Butova TS; Stepanenko AL; Kutsyna GA; Jirathitikal V; Bourinbaiar AS
    Immunotherapy; 2013 Oct; 5(10):1047-54. PubMed ID: 24088075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunotherapeutic effect of Mycobacterium vaccae on multi-drug resistant pulmonary tuberculosis].
    Luo Y; Lu S; Guo S
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb; 23(2):85-8. PubMed ID: 11778496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
    Wang W; Jin G; Ye Y; Xia X; Wang A; Zhuang Y; Li G; Sun H; Wang Z; Lin M; Chen H; Li J; Dan Z; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):108-10. PubMed ID: 11820954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172).
    Dlugovitzky D; Bottasso O; Dominino JC; Valentini E; Hartopp R; Singh M; Stanford C; Stanford J
    Respir Med; 1999 Aug; 93(8):557-62. PubMed ID: 10542989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial.
    Berth-Jones J; Arkwright PD; Marasovic D; Savani N; Aldridge CR; Leech SN; Morgan C; Clark SM; Ogilvie S; Chopra S; Harper JI; Smith CH; Rook GA; Friedmann PS
    Clin Exp Allergy; 2006 Sep; 36(9):1115-21. PubMed ID: 16961710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.
    Hernández-Pando R; Aguilar D; Orozco H; Cortez Y; Brunet LR; Rook GA
    Clin Vaccine Immunol; 2008 Nov; 15(11):1730-6. PubMed ID: 18827195
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Lin YR; Wu FY; Xiao H; Huang JL; Gong BB; Li YL; Lu N; Jiang XH; Sun QX; Zhang JF; Hu JT; Zhao YX; Li CQ
    J Aerosol Med Pulm Drug Deliv; 2021 Apr; 34(2):108-114. PubMed ID: 33691499
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial.
    Daley P; Jagannathan V; John KR; Sarojini J; Latha A; Vieth R; Suzana S; Jeyaseelan L; Christopher DJ; Smieja M; Mathai D
    Lancet Infect Dis; 2015 May; 15(5):528-34. PubMed ID: 25863562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.
    Samandari T; Agizew TB; Nyirenda S; Tedla Z; Sibanda T; Shang N; Mosimaneotsile B; Motsamai OI; Bozeman L; Davis MK; Talbot EA; Moeti TL; Moffat HJ; Kilmarx PH; Castro KG; Wells CD
    Lancet; 2011 May; 377(9777):1588-98. PubMed ID: 21492926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007.
    Kwange SO; Budambula NL
    Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn P
    Trans R Soc Trop Med Hyg; 1995; 89(1):78-82. PubMed ID: 7747316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.